Turnover
≈ €130,000 estimated
The micro format states no turnover.
ZAGRE
Overview
Lifetime
1 annual account with figurespeak €43,245 (2025)
€43,245
peak €31,456 (2025)
€31,456
peak €33,456 (2025)
€33,456
€16,142
Board1 name since 2025
1 director
Documentsfilings and deeds
29-06-202632 days before the deadline
2025micro format
Incorporation 26-091 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€2,000 100 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 11,278 companies had the same profile as ZAGRE has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,278 companies, not a prediction for ZAGRE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1028036088
Incorporation
Founding capital of €2,000, 100 shares · Appointment: (director) · 100 shares · published on 26-09-2025 · Gazette deed
First establishment
Rue du Travail 8, Seraing
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ZAGRE Seraing | €49,598 | €43,245 | 67.5% | - |
| MED-IM Services Berchem-Sainte-Agathe | €31,087 | €39,288 | 15.3% | - |
| GLOBAL LOGISTICS TT La Louvière | €54,371 | €30,252 | 38.3% | - |
| Eleonora Cottone-Apotheker-Klinisch bioloog Ghent | €47,708 | €35,862 | 62.5% | - |
| MAKOBEL Anderlecht | €29,642 | €28,566 | 76.0% | - |
| WLM Diagnostics Chaumont-Gistoux | €87,998 | €83,650 | 78.6% | - |
| ERS LAB Dilbeek | €25,274 | €41,352 | 70.6% | - |
These companies have the same main activity as ZAGRE: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €25,300 and €88,000, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 24-09-2025Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910and 1 other
- Establishment unit
- 2.379.530.6554102 Seraing, since 24-09-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 17-10-2025
Annual accounts 2025
- €43,245
- €31,456
- €33,456
- €49,598
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Insights on ZAGRE
ZAGRE has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €33,456 and a net result of €31,456.
Its solvency ranks better than 54% of 21,322 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 29-06-2026, 32 days before the deadline€43,245
€39,681
€31,456
€33,585
67.5%
3.10
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €130,000. Estimated: probably between €99,000 and €180,000.
Balance sheet
balance sheet total €49,598 on 31-12-2025What the company ownsHow it is paid for
Position in the sector
67.5%
Higher than 54% of 21,322 companies in 2025.
3.10
Higher than 54% of 20,872 companies in 2025.
63.4%
Higher than 90% of 21,172 companies in 2025.
ZAGRE
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
49,598 | |
29/58 |
49,598 | |
54/58 |
456 | |
490/1 |
49,142 | |
| Balance sheet: equity and liabilities | ||
10/49 |
49,598 | |
10/15 |
33,456 | |
10/11 |
2,000 | |
14 |
31,456 | |
17/49 |
16,142 | |
42/48 |
16,013 | |
44 |
168 | |
440/4 |
168 | |
45 |
14,857 | |
450/3 |
12,057 | |
454/9 |
2,800 | |
47/48 |
988 | |
492/3 |
129 | |
| Income statement | ||
9900 |
43,245 | |
630 |
2,541 | |
640/8 |
1,024 | |
9901 |
39,681 | |
65/66B |
168 | |
65 |
168 | |
9903 |
39,513 | |
67/77 |
8,057 | |
9904 |
31,456 | |
9905 |
31,456 | |
| Appropriation of the result | ||
9906 |
31,456 | |
| Document | ||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 29-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 29-06-2026 | 2026-00210502 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 |
|---|---|---|
| 42,222 | ||
| 33,997 | ||
| 0 | ||
| 33,585 | ||
| 67.5% | ||
| 3.10 | ||
| 0.48 | ||
| 94.0% | ||
| 63.4% | ||
| over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 |
|---|---|
| Financial fixed assets | €0 |
| €2,541 |
Source: notes to the 2025 annual accounts (statement of fixed assets)
Insights on ZAGRE
Debt's share of the balance-sheet total is 32.5%.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
current term since 24-09-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 29-06-2026
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), appointed by deed of 26-09-2025, still in office
Control
Founder
This company
ZAGRE
Equity €33,456
Profit €31,456 in 2025
Capital
- Contribution
- €2,000
- Shares
- 100
- Contribution per share
- €20
- Equity per share
- €335 in 2025
- Source
- deed of 26-09-2025
Articles of association
deed of 26-09-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Totalité des pouvoirs, faculté de déléguer, chaque administrateur agissant seul peut accomplir tous les actes nécessaires ou utiles à…”
- Share issue ruleThe articles set how and by whom new shares are issued.
- “Libérées à leur émission, En cas d’actionnaire unique-administrateur, ce dernier détermine librement, au fur et à mesure des besoins de la…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 26-09-2025 ↗
- 100 shares (100%) · €2,000 in cash
Network & group
No group
ZAGRE has no parent and no holdings in its annual accounts. is the only director. ZAGRE shares no director with another company.
Timeline
Timeline
4 events since 2025Filings
Establishments
20252026
2026
Annual accounts 2025 filed NBBmicro format · 32 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:1028036088
IncorporationFounding capital of €2,000, 100 shares · Appointment: (director) · 100 shares · published on 26-09-20257 points ▸
- Founding capital, €2,000, 100 shares
- 100 shares
- Registered office clause, Rue du Travail 8/11, 4102 Seraing
- Board rule, 1
- Director appointment, (director (not named in the articles))
- Power of attorney,
- Power of attorney,
- The deed holds 1 more point.
First establishment Rue du Travail 8, Seraing
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
Company details
Identity
- Enterprise number
- 1028.036.088
- VAT number
- BE 1028.036.088
- Peppol ID
- 0208:1028036088
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 24-09-2025
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00deed of 26-09-2025 (in French)
- Peppol
- Reachable since 17-10-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- ZAGRE in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 26-09-2025 (in French)
Activities
NACEBEL 202586910
Medical imaging and medical laboratories main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Conclure tout contrat individuel avec tout exploitant d'un laboratoire de biologie clinique ou autre; Effectuer toutes prestations de…”deed of 26-09-2025 (in French)
20 activities
- Conclure tout contrat individuel avec tout exploitant d'un laboratoire de biologie clinique ou autre
- Effectuer toutes prestations de biologie clinique et d'analyse médicale
- Assurer l'interprétation et la validation des protocoles de résultats d'analyses
- Couvrir des périodes de garde
- Exercer la fonction de consultant en matière de biologie clinique dans les laboratoires
- Évaluation, recrutement, formation spécifique et direction quotidienne du personnel du laboratoire
- Évaluation scientifique, achat et vente de systèmes analytiques, réactifs et autres dispositifs utiles au fonctionnement d'un laboratoire selon des critères scientifiques/médicaux et économiques
- Direction scientifique, économique et éthique d'un laboratoire de biologie clinique, de toxicologie, de bromatologie et d'analyses environnementales
- Récupération et diffusion dans le respect des règles d'éthiques et du RGPD en vigueur des résultats d'analyses produites
- Logistique, achat et vente de réactifs et autre matériel de laboratoire ainsi que de résultats d'analyses
- Toute autre activité susceptible de favoriser son objet tant en matière indépendante que dans le cadre de contrats avec des établissements de soins ou des confrères médecins, dans le respect du Code de Déontologie Médicale
- La mise à disposition des moyens nécessaires aux médecins pour exercer leur art au sein de la société
- Toutes les recherches et toutes études en rapport avec son objet principal
- La recherche et du développement de techniques scientifiques favorisant un diagnostic précis
- Dispenser tous avis, donner tous cours et conférences et organiser tous séminaires dans le cadre de la pratique médicale
- Toutes les opérations commerciales, mobilières ou immobilières, financières ou industrielles, se rapportant directement ou indirectement à son objet
- La constitution, la gestion et la valorisation d'un patrimoine mobilier et immobilier, notamment par l'achat, la vente, la location, la mise en location, la construction, le tout au sens le plus large
- S'intéresser par voie d'association, d'apport, de fusion, d'intervention financière ou autrement dans toutes sociétés, associations ou entreprises dont l'objet est identique, analogue ou connexe au sien ou susceptible de favoriser le développement de son entreprise ou de constituer pour elle une source de débouchés
- Exercer les fonctions d'administrateur ou liquidateur dans d'autres sociétés
- Se porter garant ou fournir des sûretés réelles pour des sociétés ou des personnes privées, au sens le plus large
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Rue du Travail 8 registered office 4102 Seraing | 24-09-2025 | 2.379.530.655 |
Buildings and parcels at the address
- Ground area
- 218 m²
- Buildings
- 230 m²
- Volume, LiDAR
- 1,558 m³
- Tallest building
- 8.6 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 62343C0053/00T022 | 218 m² | 1 · 230 m² | 8.6 m · 2 |